← All indications
Immunity
Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.
Subtype terms (11)
More specific conditions that are subtypes of Immunity in the MeSH hierarchy.
- Adaptive Immunity
2 drugs experimental
- Autoimmunity
7 drugs (2 approved, 5 experimental)
- Cross Protection
- Immunity, Herd
- Immunity, Heterologous
4 drugs (3 approved, 1 experimental)
- Immunity, Innate
10 drugs (6 approved, 4 experimental)
- Immunity, Maternally-Acquired
- Immunity, Mucosal
2 drugs (1 approved, 1 experimental)
- Plant Immunity
- Sterilizing Immunity
- T-Cell Antigen Receptor Specificity
Drugs by status
Phase 4 trials (15)
- bacille calmette-guerin
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- menitorix
- pneumococcal 13-valent conjugate vaccine
- Measles, Mumps and Rubella Vaccine, Live
- hepatitis b vaccine (recombinant)
- yellow fever vaccine 17d strain
- live attenuated influenza virus vaccine
- Tetanus and diphtheria toxoids adsorbed
- inactivated influenza vaccine
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- killed oral cholera vaccine
- human rotavirus, live attenuated
- bivalent bnt162b2
- Monovalent group C meningococcal vaccine
Phase 3 trials (3)
Phase 2 trials (2)
Phase 1 trials (3)
Other trials (29)
- vitamin d3
- antimony
- acetylcysteine
- garlic
- fluarix
- flulaval
- inulin
- keyhole limpet hemocyanin
- montanide isa51
- onion peel extract
- aluminum hydroxide
- pediococcus pentosaceus lp28
- mango
- curcuma longa
- almond
- walnut
- soybean
- agaricus
- vitamin a
- protocatechuic aldehyde
- blueberry
- Lactobacillus acidophilus
- zinc
- bifidobacterium lactis
- porphyra tenera
- nokyong
- solarplast
- oryza sativa
- Bacillus amyloliquefaciens spore